Evaluation of the cancer stem cell marker DCLK1 in patients with lymph node metastases of head and neck cancer.

CONCLUSION: DCLK1 expression might be associated with poorer clinical outcomes in HNSCC patients, specifically in HPV(-) move patients. However, larger studies are required to verify our results.
PMID: 31706685 [PubMed - as supplied by publisher]

Source: Pathology, Research and Practice - October 22, 2019 Category: Pathology Authors: Kadletz L, Kenner L, Wiebringhaus R, Jank B, Mayer C, Gurnhofer E, Konrad S, Heiduschka G Tags: Pathol Res Pract Source Type: research